当前位置：
X-MOL 学术
›
BMC Med. Genet.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel compound heterozygous TARS2 variants in a Chinese family with mitochondrial encephalomyopathy: a case report
BMC Medical Genetics ( IF 2.023 ) Pub Date : 2020-11-05 , DOI: 10.1186/s12881-020-01149-0 Xiaojing Li , Bingwei Peng , Chi Hou , Jinliang Li , Yiru Zeng , Wenxiao Wu , Yinting Liao , Yang Tian , Wen-Xiong Chen
BMC Medical Genetics ( IF 2.023 ) Pub Date : 2020-11-05 , DOI: 10.1186/s12881-020-01149-0 Xiaojing Li , Bingwei Peng , Chi Hou , Jinliang Li , Yiru Zeng , Wenxiao Wu , Yinting Liao , Yang Tian , Wen-Xiong Chen
Mitochondrial encephalomyopathy caused by bi-allelic deleterious variants in TARS2 is rare. To date, only two pedigrees were reported in the literature and the connection between the gene and disease needs further study. We report one infant who presented with limb hypertonia, epilepsy, developmental delay, and increased serum lactate from a non-consanguineous Chinese family. Whole-genome sequencing was performed to help to underlie the cause. We identified compound heterozygous variants c.470C > G, p.Thr157Arg and c.2143G > A, p.Glu715Lys in TARS2 and the variants were confirmed by Sanger sequencing. The patient was diagnosed with combined oxidative phosphorylation deficiency 21 according to the Online Mendelian Inheritance in Man (OMIM) database based on the clinical data and the deleterious effect of the two variants in TARS2 predicted by in silico tools. We presented one case diagnosed with combined oxidative phosphorylation deficiency 21 based on clinical characteristics and genetic analysis. This is the first case in China and the fourth case in the world based on our document retrieval. This study facilitates the understanding of combined oxidative phosphorylation deficiency disease and demonstrates that the next-generation sequencing has a high potential to study inherited disease with high phenotypic heterogeneity and genetic heterogeneity including mitochondrial diseases such as combined oxidative phosphorylation deficiency.
更新日期：2020-11-06
京公网安备 11010802027423号